Yale School of Medicine Launches Five-Year Type 1 Diabetes Research Effort With Bukhman Gift

CTHealthNews.com
November 16, 2026

Yale School of Medicine in New Haven received a $10 million gift from Anastasia and Igor Bukhman, through the Bukhman Foundation, to fund a five-year, multi-investigator research program focused on reversing and ultimately curing type 1 diabetes.

 

The program brings together researchers in immunology, endocrinology, cancer immunology and engineering.

 

Nancy J. Brown, MD, the Jean and David W. Wallace Dean of Yale School of Medicine, said: “We are grateful to Anastasia and Igor Bukhman for their generosity and for the trust they have placed in our investigators. This philanthropic support will enable these researchers to transform how type 1 diabetes is treated by developing precision therapies to modify its course and eventually prevent it.”

 

Diabetes affects members of the Bukhman family, including Anastasia Bukhman.

 

“It’s a condition that has been in our family for a long time,” she said, “and one that has played a big role in shaping the work we do today.”

 

The research includes work to halt the immune attack on beta cells and develop personalized treatment approaches based on each patient’s genetic and immunologic profile.

 

Kevan Herold, MD, the C.N.H. Long Professor of Immunobiology and of Medicine (Endocrinology), who leads that work, said: “The gift funds a number of projects which are all focused on stopping the immune-mediated pathogenesis of type 1 diabetes and restoring lost insulin-producing beta cells. The research is very goal-directed, and that goal is the prevention or reversal of disease. The studies will develop personalized approaches to treatment involving analyses of gene signatures, immunologic features, and beta cells from individuals with and at risk for diabetes.”

 

The program also supports five other Yale scientists. Esen Sefik, PhD, an assistant professor of immunobiology, works on disease modeling and variation among patients’ immune cells. Richard Flavell, PhD, a Sterling Professor of Immunobiology, engineers mice to study the immune system. Nikhil Joshi, PhD, a professor of immunobiology and co-leader of Cancer Immunology at Yale Cancer Center, applies cancer immunology to immune cell behavior and tolerance. Richard Kibbey, MD, PhD, an Ensign Professor of Medicine, studies beta-cell biology and replacement insulin-producing cells. John Tsang, PhD, a Brady Professor of Immunobiology and Biomedical Engineering and director of Yale’s Center for Systems and Engineering Immunology, applies computational modeling to immune data.

Recent News

OpenClassActions.com
11/16/26
November 16, 2026